Implantable drug delivery device and methods
US10532132B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | Jun 5, 2013 |
| Grant date | Jan 14, 2020 |
| Priority date | — |
| Expiry date | May 18, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2300/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method is provided for local controlled delivery of a drug to the seminal vesicle, the prostate, the ejaculatory duct, or the vas deferens of a patient in need of treatment. In one embodiment, the method includes implanting a resorbable drug delivery device within the seminal vesicle, the prostate, the ejaculatory duct, or the vas deferens of the patient. The drug delivery device may include an elastic device body housing at least one drug reservoir which contains at least one drug. In a preferred embodiment, the method further includes releasing the drug from the device in a controlled manner to, typically directly to, the seminal vesicle, the prostate, the ejaculatory duct, or the vas deferens.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.